| Distribution | Full List | Categories |
| by Country | by Vaccine |
| PEOPLE VACCINATED | LAST 7 DAYS | |||||
| countries over 1M population |
1st dose |
last dose |
1st dose |
last dose |
any dose |
|
| United Arab Emirates |
100.0% 9,890,532 |
97.7% 9,663,049 |
0.0% | 0.1% |
0.4% 44k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sputnik V | ||||||
| Portugal |
94.8% 9,663,542 |
92.3% 9,415,073 |
0.0% | 0.1% |
0.4% 44k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Cuba |
94.1% 10,656,797 |
87.8% 9,946,616 |
0.1% | 0.1% |
0.6% 66k |
|
| Abdala, Soberana Plus, Soberana02 | ||||||
| Chile |
93.7% 17,914,689 |
91.3% 17,458,624 |
0.0% | 0.1% |
2.8% 535k |
|
| CanSino, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Argentina |
90.8% 41,021,045 |
82.3% 37,217,445 |
0.0% | 0.1% |
0.9% 415k |
|
| CanSino, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Canada |
89.5% 33,763,325 |
82.9% 31,296,495 |
1.1% | 0.1% |
1.6% 616k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| China |
89.3% 1,284,935,000 |
86.8% 1,249,688,000 |
0.2% | 0.2% | ||
| CanSino, IMBCAMS, KCONVAC, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, ZF2001 | ||||||
| Cambodia |
89.1% 14,892,264 |
84.7% 14,151,943 |
0.2% | 0.2% |
2.5% 413k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac | ||||||
| New Zealand |
88.9% 4,287,915 |
84.8% 4,091,701 |
0.0% | 0.1% |
0.3% 16k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Hong Kong |
88.2% 6,609,485 |
81.0% 6,074,063 |
0.4% | 0.8% |
2.3% 176k |
|
| Pfizer/BioNTech, Sinovac | ||||||
| Spain |
88.1% 41,200,263 |
86.4% 40,414,329 |
0.0% | 0.1% |
0.2% 84k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Peru |
88.1% 29,031,992 |
81.0% 26,704,946 |
0.2% | 0.4% |
2.2% 716k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| South Korea |
87.8% 45,032,129 |
86.9% 44,548,135 |
0.0% | 0.0% |
2.6% 1,355k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Australia |
87.4% 22,278,774 |
84.4% 21,527,099 |
0.0% | 0.1% |
0.5% 128k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Costa Rica |
86.4% 4,401,102 |
80.2% 4,084,348 |
0.3% | 0.6% |
2.1% 108k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Nicaragua |
86.1% 5,706,494 |
70.5% 4,670,937 |
0.4% | 1.0% |
1.4% 93k |
|
| Abdala, Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Soberana02, Sputnik Light, Sputnik V | ||||||
| Brazil |
85.9% 182,599,066 |
77.1% 163,923,507 |
0.1% | 0.3% |
1.1% 2,413k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Uruguay |
85.9% 2,983,082 |
82.4% 2,862,540 |
0.1% | 0.1% |
0.6% 22k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Malaysia |
85.8% 27,770,374 |
82.6% 26,719,207 |
0.2% | 0.6% |
0.9% 276k |
|
| CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Singapore |
85.7% 5,011,993 |
85.1% 4,980,270 |
0.0% | 0.2% |
0.7% 39k |
|
| Moderna, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Ecuador |
85.7% 15,111,720 |
78.8% 13,895,971 |
0.1% | 0.2% |
1.1% 194k |
|
| CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Italy |
84.0% 50,762,480 |
79.2% 47,906,389 |
0.0% | 0.0% |
0.4% 233k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Denmark |
83.5% 4,837,277 |
82.8% 4,798,698 |
0.0% | 0.0% |
0.1% 5k |
|
| Johnson&Johnson, Moderna, Pfizer/BioNTech | ||||||
| Taiwan |
82.9% 19,737,798 |
78.2% 18,634,418 |
0.4% | 0.4% |
2.8% 673k |
|
| Medigen, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| France |
82.8% 54,057,003 |
80.5% 52,541,424 |
0.0% | 0.0% |
0.4% 250k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Colombia |
82.8% 42,126,214 |
69.7% 35,468,805 |
0.1% | 0.5% |
1.0% 501k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Ireland |
82.6% 4,078,760 |
81.5% 4,023,130 |
0.0% | 0.0% |
0.3% 16k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Vietnam |
82.1% 79,947,189 |
79.9% 77,754,108 |
0.3% | 0.1% |
2.5% 2,415k |
|
| Abdala, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Qatar |
81.9% 2,360,308 |
77.0% 2,218,292 |
0.8% 21k |
|||
| Moderna, Pfizer/BioNTech | ||||||
| Japan |
81.6% 103,153,093 |
80.2% 101,458,832 |
0.1% | 0.2% |
2.6% 3,305k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Finland |
81.4% 4,509,932 |
78.0% 4,320,476 |
0.0% | 0.0% |
0.3% 15k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Thailand |
80.4% 56,109,303 |
73.3% 51,178,475 |
0.2% | 0.4% |
1.4% 940k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Panama |
80.3% 3,464,188 |
71.2% 3,074,298 |
0.2% | 0.4% |
1.0% 45k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Kuwait |
80.1% 3,419,874 |
77.1% 3,294,466 |
0.1% | 0.1% |
0.6% 23k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Norway |
80.0% 4,334,823 |
74.4% 4,032,616 |
0.0% | 0.0% |
0.1% 6k |
|
| Moderna, Pfizer/BioNTech | ||||||
| Belgium |
79.7% 9,236,770 |
78.8% 9,138,378 |
0.0% | 0.0% |
0.1% 12k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Sri Lanka |
79.6% 17,033,222 |
67.5% 14,449,321 |
0.0% | 0.0% |
0.2% 39k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Laos |
79.2% 5,766,217 |
66.4% 4,828,012 |
0.4% | 1.1% |
1.5% 108k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Mauritius |
78.7% 1,000,474 |
75.8% 963,452 |
2.8% 35k |
|||
| Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Netherlands |
78.6% 13,464,173 |
72.4% 12,404,222 |
0.0% | 0.0% |
0.2% 29k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| United Kingdom |
78.3% 53,184,869 |
73.2% 49,727,305 |
0.1% | 0.1% |
0.4% 286k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Bangladesh |
78.2% 128,729,921 |
70.5% 116,139,241 |
0.1% | 0.3% |
0.8% 1,323k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Venezuela |
77.9% 22,157,232 |
50.2% 14,287,370 |
||||
| Abdala, Sinopharm/Beijing, Sinovac, Soberana02, Sputnik Light, Sputnik V | ||||||
| United States |
77.8% 257,641,065 |
66.4% 219,675,939 |
0.1% | 0.1% |
0.6% 1,855k |
|
| Johnson&Johnson, Moderna, Pfizer/BioNTech | ||||||
| Sweden |
77.5% 7,826,928 |
75.6% 7,631,111 |
0.0% | 0.0% |
2.3% 235k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Israel |
77.5% 6,706,732 |
70.9% 6,135,649 |
0.0% | 0.0% |
0.1% 7k |
|
| Moderna, Pfizer/BioNTech | ||||||
| Germany |
77.0% 64,497,522 |
76.9% 64,411,509 |
0.0% | 0.0% |
0.6% 530k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Iran |
76.6% 64,328,567 |
68.5% 57,544,801 |
0.1% | 0.1% |
0.4% 302k |
|
| COVIran Barekat, Covaxin, FAKHRAVAC, Oxford/AstraZeneca, Razi Cov Pars, Sinopharm/Beijing, Soberana02, SpikoGen, Sputnik V | ||||||
| Nepal |
76.4% 22,261,575 |
67.2% 19,586,196 |
0.3% | 0.5% |
2.6% 767k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Greece |
75.9% 7,910,893 |
73.1% 7,617,186 |
0.0% | 0.0% |
0.7% 75k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Saudi Arabia |
75.9% 26,424,390 |
71.1% 24,760,229 |
0.2% | 0.2% |
1.1% 400k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Austria |
75.8% 6,822,345 |
73.4% 6,607,157 |
0.0% | 0.0% |
0.1% 12k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Indonesia |
72.9% 199,346,528 |
60.4% 165,134,259 |
0.2% | 0.5% |
1.3% 3,448k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| India |
72.7% 1,003,162,202 |
62.2% 858,800,580 |
0.2% | 0.7% |
1.0% 14,467k |
|
| Covaxin, Oxford/AstraZeneca, Sputnik V | ||||||
| Bahrain |
72.5% 1,234,388 |
71.6% 1,218,620 |
0.0% | 0.0% |
0.2% 3k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik Light, Sputnik V | ||||||
| Lithuania |
71.7% 1,950,603 |
68.9% 1,874,507 |
0.0% | 0.0% |
0.1% 2k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Latvia |
71.3% 1,344,740 |
69.1% 1,303,861 |
0.0% | 0.0% |
0.1% 2k |
|
| Johnson&Johnson, Moderna, Novavax, Pfizer/BioNTech | ||||||
| El Salvador |
70.8% 4,595,639 |
66.3% 4,298,297 |
0.1% | 0.1% |
0.8% 52k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Switzerland |
70.3% 6,080,794 |
69.3% 5,994,651 |
0.0% | 0.0% |
0.1% 9k |
|
| Johnson&Johnson, Moderna, Pfizer/BioNTech | ||||||
| Mongolia |
69.3% 2,272,965 |
66.4% 2,175,617 |
0.0% | 0.0% |
0.1% 3k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Rwanda |
69.1% 8,949,182 |
64.1% 8,304,883 |
0.1% | 0.3% | ||
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Turkey |
68.6% 57,818,874 |
62.9% 53,034,655 |
0.0% | 0.0% |
0.1% 75k |
|
| Pfizer/BioNTech, Sinovac, Turkovac | ||||||
| Morocco |
67.5% 24,901,908 |
63.3% 23,380,122 |
0.0% | 0.0% |
0.1% 38k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Mexico |
66.5% 85,797,486 |
62.0% 79,945,002 |
0.1% |
2.0% 2,609k |
||
| CanSino, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V | ||||||
| Dominican Republic |
66.4% 7,207,046 |
55.0% 5,961,599 |
0.0% | 0.1% |
0.1% 14k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Hungary |
66.3% 6,406,150 |
64.1% 6,192,142 |
0.0% | 0.0% |
0.1% 13k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Czechia |
65.0% 6,957,628 |
64.1% 6,868,129 |
0.0% | 0.0% |
0.2% 16k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Estonia |
64.9% 860,615 |
63.7% 844,872 |
0.0% | 0.0% |
0.2% 2k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Belarus |
64.6% 6,100,010 |
60.0% 5,667,040 |
0.8% | 0.9% |
1.9% 183k |
|
| CoviVac, Sinopharm/Beijing, Sputnik Light, Sputnik V | ||||||
| Oman |
63.8% 3,259,190 |
59.3% 3,027,855 |
0.0% | 0.0% |
0.1% 6k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V | ||||||
| Botswana |
62.7% 1,475,516 |
56.7% 1,333,463 |
0.2% | 0.3% | ||
| Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Bolivia |
61.3% 7,159,929 |
50.6% 5,904,881 |
0.1% | 0.2% |
0.6% 70k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Slovenia |
60.9% 1,265,209 |
58.8% 1,221,276 |
0.0% | 0.0% |
0.1% 1k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Tunisia |
60.8% 7,189,498 |
53.9% 6,366,918 |
0.1% | 0.1% |
0.4% 45k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Pakistan |
60.8% 134,313,917 |
55.1% 121,757,972 |
0.1% | 0.2% |
0.4% 788k |
|
| CanSino, Covaxin, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Poland |
59.9% 22,655,895 |
59.3% 22,434,094 |
0.0% | 0.1% |
0.2% 83k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Timor |
59.2% 781,062 |
46.9% 618,046 |
0.2% | 0.7% |
1.3% 17k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Uzbekistan |
56.8% 19,028,496 |
43.2% 14,440,696 |
0.5% | 0.4% |
2.5% 849k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik Light, Sputnik V, ZF2001 | ||||||
| Croatia |
56.3% 2,313,107 |
54.6% 2,241,736 |
0.0% | 0.0% |
0.1% 4k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Russia |
55.4% 80,862,100 |
50.4% 73,576,259 |
0.2% | 0.2% |
0.2% 354k |
|
| EpiVacCorona, Sputnik V | ||||||
| Myanmar |
55.4% 30,142,895 |
42.5% 23,114,428 |
2.2% | 1.2% |
3.6% 1,969k |
|
| Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Paraguay |
54.4% 3,881,480 |
48.3% 3,446,930 |
0.0% | 0.8% |
1.0% 75k |
|
| Covaxin, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Tajikistan |
54.1% 5,158,199 |
51.2% 4,886,268 |
0.1% | 0.3% |
2.2% 214k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V | ||||||
| Honduras |
53.4% 5,291,709 |
49.5% 4,899,315 |
0.3% | 0.3% |
1.6% 159k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V | ||||||
| Trinidad and Tobago |
53.4% 747,508 |
50.8% 711,305 |
0.0% | 0.0% |
0.1% 2k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Azerbaijan |
52.7% 5,340,053 |
47.7% 4,840,220 |
0.0% | 0.0% |
0.3% 26k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V | ||||||
| Slovakia |
51.7% 2,821,112 |
50.7% 2,765,755 |
0.0% |
0.0% 2k |
||
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V | ||||||
| Philippines |
51.2% 56,110,301 |
61.9% 67,792,216 |
0.5% |
1.1% 1,232k |
||
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Kazakhstan |
50.0% 9,394,344 |
48.0% 9,010,266 |
0.1% | 0.3% |
0.4% 75k |
|
| QazVac, Sinopharm/Beijing, Sputnik V | ||||||
| Serbia |
49.2% 3,347,209 |
48.0% 3,269,374 |
0.0% | 0.0% |
0.1% 4k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Kosovo |
46.7% 902,575 |
42.5% 822,042 |
0.0% | 0.0% |
0.0% 1k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Jordan |
46.7% 4,763,118 |
44.0% 4,484,687 |
0.1% | 0.1% |
0.2% 17k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Mozambique |
45.6% 14,243,939 |
42.0% 13,130,997 |
0.4% 118k |
|||
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Guatemala |
45.3% 8,121,065 |
34.2% 6,122,216 |
0.3% | 0.2% |
1.2% 216k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V | ||||||
| Egypt |
45.2% 46,221,961 |
33.3% 34,130,697 |
0.2% | 0.4% |
0.8% 797k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Albania |
44.9% 1,293,234 |
42.8% 1,230,856 |
0.1% | 0.1% |
0.4% 12k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V | ||||||
| Lesotho |
43.6% 933,825 |
34.3% 735,610 |
1.4% | 0.1% |
0.3% 6k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| North Macedonia |
41.0% 853,261 |
40.1% 836,358 |
0.0% | 0.0% |
0.1% 2k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Georgia |
40.6% 1,618,407 |
31.7% 1,263,668 |
0.1% | 0.0% |
0.1% 4k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Zimbabwe |
39.5% 5,866,832 |
24.7% 3,672,516 |
0.3% | 0.2% |
0.7% 100k |
|
| Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Palestine |
39.2% 2,001,813 |
34.7% 1,768,549 |
0.0% | 0.0% |
0.0% 2k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Armenia |
38.1% 1,130,313 |
33.2% 984,868 |
0.1% | 0.2% |
0.3% 8k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, Sputnik Light, Sputnik V | ||||||
| Lebanon |
37.0% 2,524,596 |
32.5% 2,215,768 |
0.0% | 0.1% |
0.1% 8k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Angola |
36.7% 12,059,919 |
19.2% 6,327,907 |
0.2% | 0.2% | ||
| Oxford/AstraZeneca | ||||||
| Ukraine |
36.1% 15,774,300 |
34.7% 15,153,577 |
0.2% | 0.0% |
0.4% 171k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| South Africa |
35.9% 21,298,735 |
30.9% 18,339,920 |
0.2% | 0.2% |
0.4% 269k |
|
| Johnson&Johnson, Pfizer/BioNTech | ||||||
| Liberia |
34.6% 1,751,520 |
28.4% 1,438,154 |
3.0% | 1.8% |
3.0% 154k |
|
| Oxford/AstraZeneca | ||||||
| Guinea |
34.0% 4,464,014 |
19.1% 2,508,809 |
1.5% | 0.0% |
0.2% 31k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Uganda |
33.7% 15,409,049 |
22.4% 10,235,247 |
0.1% | 0.1% |
0.2% 107k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Mauritania |
33.6% 1,561,597 |
22.9% 1,066,564 |
0.0% | 0.0% |
4.0% 186k |
|
| Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Libya |
32.2% 2,214,303 |
16.6% 1,140,236 |
0.1% | 0.0% |
0.1% 7k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Cote d'Ivoire |
30.1% 7,952,458 |
20.6% 5,437,294 |
0.0% | 0.1% |
0.2% 48k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Ghana |
29.9% 9,274,857 |
17.8% 5,532,611 |
0.2% | 0.4% | ||
| Oxford/AstraZeneca, Sputnik V | ||||||
| Bosnia and Herzegovina |
28.8% 943,394 |
25.8% 846,080 |
0.3% | 0.3% |
0.9% 30k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V | ||||||
| Romania |
28.5% 5,474,507 |
42.1% 8,096,752 |
0.0% |
0.0% 8k |
||
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| WORLD |
27.5% 2,147,483,647 |
27.5% 2,147,483,647 |
||||
| Bulgaria |
27.4% 1,904,143 |
29.6% 2,055,820 |
0.0% |
0.1% 6k |
||
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Jamaica |
26.7% 789,860 |
23.2% 686,059 |
0.1% | 0.1% |
0.2% 5k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Guinea-Bissau |
26.4% 519,455 |
17.4% 341,495 |
0.0% | 0.0% |
0.0% 0k |
|
| Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Iraq |
26.1% 10,517,211 |
18.3% 7,376,481 |
0.1% | 0.1% |
0.2% 91k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Benin |
26.0% 3,152,148 |
21.6% 2,619,609 |
0.3% | 0.3% |
0.7% 81k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Sierra Leone |
24.9% 1,985,041 |
16.5% 1,312,828 |
0.8% | 0.6% | ||
| Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Togo |
24.6% 2,037,429 |
18.8% 1,557,538 |
0.9% |
1.0% 81k |
||
| Oxford/AstraZeneca | ||||||
| Moldova |
23.5% 948,882 |
26.3% 1,059,746 |
0.0% |
0.1% 3k |
||
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Kyrgyzstan |
23.5% 1,530,218 |
19.5% 1,274,499 |
0.1% | 0.1% |
0.4% 25k |
|
| Sinopharm/Beijing, Sputnik V | ||||||
| Kenya |
23.2% 12,502,390 |
16.9% 9,069,872 |
0.4% | 0.5% |
0.1% 43k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Ethiopia |
21.5% 24,769,870 |
18.5% 21,290,883 |
0.1% | 0.1% |
0.0% 19k |
|
| Covaxin, Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac | ||||||
| Central African Republic |
21.0% 1,015,918 |
20.5% 988,591 |
0.4% | 0.4% |
0.1% 5k |
|
| Covaxin, Oxford/AstraZeneca | ||||||
| Equatorial Guinea |
18.9% 264,393 |
15.1% 212,359 |
0.0% | 0.0% |
0.1% 1k |
|
| Sinopharm/Beijing | ||||||
| Algeria |
17.9% 7,840,131 |
14.8% 6,481,186 |
0.1% | 0.1% |
0.0% 10k |
|
| Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Namibia |
17.9% 453,540 |
15.6% 395,625 |
0.0% | 0.1% | ||
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Syria |
14.1% 2,459,791 |
8.7% 1,524,341 |
0.1% | 0.3% |
0.4% 66k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Gambia |
13.7% 331,266 |
13.2% 318,161 |
0.0% | 0.0% |
0.0% 0k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Somalia |
13.7% 2,173,928 |
8.7% 1,385,138 |
0.4% | 0.0% |
0.4% 65k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac | ||||||
| Afghanistan |
13.6% 5,287,027 |
11.9% 4,637,327 |
0.1% | 0.1% |
0.1% 29k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Zambia |
13.5% 2,487,149 |
13.2% 2,420,028 |
0.2% |
0.4% 73k |
||
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Sudan |
13.5% 5,919,717 |
8.2% 3,610,352 |
0.0% | 0.1% |
0.1% 29k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Gabon |
13.5% 300,192 |
11.4% 254,453 |
0.0% | 0.0% |
0.1% 1k |
|
| Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Chad |
13.5% 2,212,530 |
12.7% 2,087,559 |
0.1% | 0.1% |
0.1% 23k |
|
| Sinopharm/Beijing | ||||||
| Congo |
12.6% 693,003 |
11.6% 640,464 |
0.0% |
0.0% 2k |
||
| Moderna, Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V | ||||||
| Nigeria |
12.2% 25,056,663 |
7.1% 14,624,418 |
0.4% | 0.2% |
0.6% 1,327k |
|
| Oxford/AstraZeneca | ||||||
| Tanzania |
10.9% 6,483,895 |
5.8% 3,467,885 |
0.9% | 0.1% |
0.6% 344k |
|
| Johnson&Johnson, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Burkina Faso |
10.3% 2,158,705 |
5.9% 1,243,268 |
0.1% | 0.1% |
0.1% 26k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Niger |
9.1% 2,190,527 |
6.4% 1,549,016 |
0.0% | 0.0% |
0.0% 1k |
|
| Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Senegal |
8.7% 1,457,116 |
6.2% 1,039,257 |
0.0% | 0.0% |
0.1% 8k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Malawi |
8.4% 1,596,607 |
4.8% 908,688 |
0.0% | 0.0% |
0.1% 10k |
|
| Johnson&Johnson, Oxford/AstraZeneca | ||||||
| Mali |
6.8% 1,384,090 |
5.1% 1,023,624 |
0.1% | 0.1% | ||
| Oxford/AstraZeneca | ||||||
| Cameroon |
5.8% 1,552,320 |
4.6% 1,209,108 |
0.0% | 0.0% |
0.0% 3k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| South Sudan |
5.5% 619,938 |
5.2% 576,431 |
0.1% | 0.1% |
0.1% 9k |
|
| Johnson&Johnson, Oxford/AstraZeneca | ||||||
| Eswatini |
4.5% 387,468 |
3.9% 336,066 |
0.0% | 0.0% |
0.1% 5k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Madagascar |
4.3% 1,185,420 |
3.8% 1,051,811 |
0.1% | 0.0% |
0.0% 0k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Papua New Guinea |
3.6% 322,687 |
2.9% 263,313 |
0.0% | 0.0% |
0.0% 4k |
|
| Oxford/AstraZeneca | ||||||
| Yemen |
2.2% 656,957 |
1.4% 418,785 |
0.0% | 0.0% |
0.0% 4k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Sinovac | ||||||
| Haiti |
1.5% 175,526 |
1.1% 122,181 |
0.0% | 0.0% |
0.0% 1k |
|
| Johnson&Johnson, Moderna | ||||||
| Democratic Republic of Congo |
0.9% 802,182 |
0.6% 515,732 |
0.0% | 0.0% |
0.0% 6k |
|
| Oxford/AstraZeneca | ||||||
| Burundi |
0.1% 11,083 |
0.1% 10,522 |
0.0% | 0.0% |
0.0% 0k |
|
| Johnson&Johnson, Sinopharm/Beijing | ||||||
| PEOPLE VACCINATED | LAST 7 DAYS | |||||
| countries below 1M population |
1st dose |
last dose |
1st dose |
last dose |
any dose |
|
| Gibraltar |
124.9% 42,074 |
122.9% 41,421 |
0.1% |
0.8% 0k |
||
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Malta |
107.7% 475,435 |
106.0% 468,149 |
0.1% | 0.1% |
1.4% 6k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Niue |
102.0% 1,650 |
87.6% 1,417 |
1.2% |
6.1% 0k |
||
| Pfizer/BioNTech | ||||||
| Pitcairn |
100.0% 47 |
100.0% 47 |
||||
| Oxford/AstraZeneca | ||||||
| Samoa |
94.4% 187,393 |
74.7% 148,288 |
0.4% | 2.8% |
6.1% 12k |
|
| Oxford/AstraZeneca | ||||||
| Brunei |
94.2% 412,058 |
92.7% 405,414 |
0.9% | 0.0% |
1.4% 6k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Macao |
92.5% 600,640 |
85.8% 557,428 |
0.5% | 1.4% |
3.3% 21k |
|
| Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Cayman Islands |
92.5% 60,763 |
89.4% 58,781 |
0.0% | 0.1% |
0.2% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Iceland |
90.8% 309,770 |
85.0% 290,193 |
0.0% | 0.0% |
0.1% 0k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Bhutan |
89.7% 692,170 |
86.9% 670,303 |
0.1% | 0.5% |
0.9% 7k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Nauru |
87.3% 9,464 |
79.2% 8,585 |
1.0% | 2.8% |
18.9% 2k |
|
| Oxford/AstraZeneca | ||||||
| Seychelles |
85.8% 84,387 |
81.7% 80,290 |
0.0% | |||
| Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V | ||||||
| Cook Islands |
85.4% 15,004 |
83.6% 14,676 |
0.1% | 0.6% |
57.1% 10k |
|
| Pfizer/BioNTech | ||||||
| Faeroe Islands |
85.4% 41,715 |
83.7% 40,895 |
0.0% | 0.0% |
0.3% 0k |
|
| Moderna, Pfizer/BioNTech | ||||||
| Aruba |
82.8% 88,386 |
76.7% 81,937 |
0.1% | 0.1% |
0.2% 0k |
|
| Pfizer/BioNTech | ||||||
| Jersey |
82.3% 83,173 |
79.3% 80,193 |
0.1% | 0.3% |
1.1% 1k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Isle of Man |
81.8% 69,532 |
78.8% 67,024 |
0.0% | 0.1% |
0.2% 0k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Turks and Caicos Islands |
81.3% 31,491 |
76.1% 29,458 |
0.2% | 0.2% |
0.3% 0k |
|
| Pfizer/BioNTech | ||||||
| Guernsey |
80.8% 54,146 |
76.6% 51,351 |
0.5% 0k |
|||
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Cyprus |
78.5% 687,926 |
73.7% 645,292 |
0.2% 2k |
|||
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Bermuda |
77.8% 48,424 |
76.2% 47,464 |
0.1% | 0.2% |
0.2% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| San Marino |
77.6% 26,345 |
69.6% 23,624 |
0.2% 0k |
|||
| Pfizer/BioNTech, Sputnik V | ||||||
| Luxembourg |
76.8% 480,640 |
6.1% 37,870 |
0.0% |
0.1% 1k |
||
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Fiji |
76.4% 685,353 |
70.4% 631,326 |
0.0% | 0.0% |
0.1% 0k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Falkland Islands |
75.6% 2,632 |
51.0% 1,775 |
0.8% | 1.7% |
2.4% 0k |
|
| Oxford/AstraZeneca | ||||||
| Andorra |
74.9% 57,850 |
69.1% 53,406 |
0.1% 0k |
|||
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Tonga |
73.8% 77,994 |
68.0% 71,854 |
1.0% | 1.5% |
13.3% 14k |
|
| Oxford/AstraZeneca | ||||||
| Maldives |
73.7% 398,579 |
71.0% 383,925 |
0.0% | 0.0% |
0.1% 1k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Monaco |
73.6% 28,875 |
65.4% 25,667 |
0.4% | 0.4% |
2.8% 1k |
|
| Pfizer/BioNTech | ||||||
| Bonaire Sint Eustatius and Saba |
72.9% 19,109 |
63.8% 16,736 |
2.5% | 2.8% |
5.2% 1k |
|
| Moderna, Pfizer/BioNTech | ||||||
| Greenland |
72.7% 41,243 |
67.8% 38,502 |
0.0% 0k |
|||
| Moderna | ||||||
| Anguilla |
70.8% 10,622 |
65.8% 9,874 |
0.2% | 0.7% |
1.2% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Liechtenstein |
70.1% 26,727 |
69.2% 26,404 |
0.1% 0k |
|||
| Johnson&Johnson, Moderna, Pfizer/BioNTech | ||||||
| French Polynesia |
66.5% 186,801 |
64.4% 180,807 |
0.1% |
0.1% 0k |
||
| Johnson&Johnson, Pfizer/BioNTech | ||||||
| New Caledonia |
65.9% 188,104 |
63.0% 179,994 |
0.0% | 0.0% |
0.1% 0k |
|
| Pfizer/BioNTech | ||||||
| Kiribati |
65.8% 78,620 |
46.3% 55,333 |
1.2% 1k |
|||
| Oxford/AstraZeneca | ||||||
| Curacao |
65.8% 107,902 |
60.3% 99,004 |
0.1% | 0.2% |
0.6% 1k |
|
| Moderna, Pfizer/BioNTech | ||||||
| Antigua and Barbuda |
65.3% 63,918 |
63.0% 61,687 |
0.0% | 0.1% |
0.1% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V | ||||||
| Sint Maarten (Dutch part) |
65.2% 27,974 |
60.6% 25,970 |
0.1% | 0.1% |
0.5% 0k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Cape Verde |
63.8% 354,533 |
55.2% 306,782 |
0.1% | 0.1% |
0.5% 3k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| British Virgin Islands |
63.7% 19,260 |
58.9% 17,817 |
0.1% | 0.1% |
0.2% 0k |
|
| Johnson&Johnson, Oxford/AstraZeneca | ||||||
| Guyana |
60.3% 474,392 |
46.3% 364,336 |
0.1% | 0.1% |
0.2% 2k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Belize |
59.6% 237,071 |
53.0% 210,905 |
0.1% | 0.1% |
0.2% 1k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Saint Kitts and Nevis |
58.6% 31,162 |
49.4% 26,294 |
0.1% | 0.1% |
0.2% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Wallis and Futuna |
57.7% 6,483 |
57.4% 6,457 |
0.4% 0k |
|||
| Moderna | ||||||
| Barbados |
56.3% 161,727 |
52.9% 151,962 |
0.0% | 0.1% |
0.1% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Vanuatu |
56.1% 172,232 |
38.5% 118,158 |
6.4% |
6.4% 20k |
||
| Oxford/AstraZeneca | ||||||
| Sao Tome and Principe |
51.9% 113,708 |
39.7% 86,914 |
0.1% | 0.1% |
0.5% 1k |
|
| Oxford/AstraZeneca | ||||||
| Montenegro |
46.3% 290,610 |
45.0% 282,651 |
0.0% | 0.0% |
0.1% 1k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Suriname |
45.6% 267,593 |
40.5% 237,596 |
0.0% | 0.0% |
0.0% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Dominica |
45.3% 32,598 |
41.9% 30,190 |
0.0% | 0.1% |
0.1% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Bahamas |
42.3% 166,471 |
40.2% 157,964 |
0.1% | 0.1% |
0.3% 1k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Solomon Islands |
41.2% 283,298 |
20.5% 140,525 |
4.7% |
4.7% 32k |
||
| Oxford/AstraZeneca | ||||||
| Comoros |
39.2% 341,302 |
34.6% 301,218 |
0.0% |
0.1% 0k |
||
| Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Grenada |
38.6% 43,419 |
33.9% 38,186 |
0.0% | 0.0% |
0.1% 0k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Montserrat |
38.0% 1,898 |
36.5% 1,827 |
||||
| Oxford/AstraZeneca | ||||||
| Saint Vincent and the Grenadines |
32.6% 36,167 |
27.3% 30,306 |
0.0% 0k |
|||
| Oxford/AstraZeneca | ||||||
| Saint Lucia |
32.0% 58,835 |
29.1% 53,522 |
0.0% | 0.0% |
0.1% 0k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Djibouti |
15.8% 156,352 |
11.8% 116,303 |
0.2% | 0.2% |
0.2% 2k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||